Ro

A SPAC deal announced Monday could help accelerate the manufacturing of a promising weight loss drug targeting over 150 million people.  The SPAC Deal: Gelesis announced a SPAC merger with Capstar Special Purpose Acquisition Corp (NYSE: CPSR). The deal values the company at a pro forma market...

Interest in telemedicine has soared during the coronavirus pandemic as health care patients sought continuity during the crisis by going virtual. That’s according to Conversion Labs Inc (OTCQB: CVLBD) CEO Justin Schreiber, who told Benzinga his business tripled as the coronavirus...